PPARδ agonist 8

• UNSPSC Description:

  Pparδ agonist 8 is a potent agonist of Pparδ. The peroxisome proliferator-activated receptor (PPAR) is a member of the intranuclear receptor transcription factor superfamily that plays a key role in the regulation of metabolic homeostasis, inflammation, cell growth and differentiation in vivo. Pparδ agonist 8 has the potential for the research of non-alcoholic fatty liver disease (NAFLD) (extracted from patent WO2021169769A1, compound TM2)[1].

• Target Antigen:

  PPAR

• Type:

  Reference compound

• Related Pathways:

  Cell Cycle/DNA Damage;Metabolic Enzyme/Protease;Vitamin D Related/Nuclear Receptor

• Applications:

  Metabolism-protein/nucleotide metabolism

• Field of Research:

  Metabolic Disease

• Assay Protocol:

  https://www.medchemexpress.com/pparδ-agonist-8.html

• Solubility:

  10 mM in DMSO

• Smiles:

  CC(C)(OC1=C(C)C=C(CCC(O)C2=CC3=CC=CC=C3N=C2OC)C=C1C)C(O)=O

• Molecular Weight:

  423.50

• References & Citations:

  [1]Shoujun Chen, et al. Aromatic compounds and pharmaceutical compositions and uses thereof. Patent WO2021169769A1.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  2697129-55-6